Table 3

 Ibuprofen in febrile asthmatic children

CitationStudy groupStudy typeOutcomeKey resultsComments
Lesko et al (2002)2Total 1879 febrile children 6 mth–12 years receiving asthma medicationGroup1: 632 children receiving paracetamol 12 mg/kg/doseGroup 2: 636 children receiving ibuprofen 5 mg/kg/doseGroup 3: 611 children receiving ibuprofen 10 mg/kg/doseRandomised controlled trialOutpatient visits for asthma or hospitalisation for asthma during 4 weeks post-medication69 (3.4%) documented outpatient visits: 32 in group 1 and 37 in groups 2 and 3Ibuprofen was found to be less likely to exacerbate asthma when compared to paracetamol. Children with known hypersensitivity to paracetamol or NSAIDs were excluded
McIntyre and Hull (1996)5Febrile inpatient children (2 mth–12 years)Group 1: 76 received ibuprofen (11 had wheeze or asthma, 21 had a history of asthma or wheezing)Group 2: 74 received paracetamol (4 with asthma or wheezing and 12 with a history of asthma or wheezing)Randomised controlled trialChange in axillary temperature, palatability, changes in clinical condition, number and nature of adverse effects10/76 (13%) patients in the ibuprofen group had 16 adverse events, 14/74 (19%) patients in the paracetamol group had 18 events. This was statistically not significant. No patients had an asthma attack, but two became wheezy, both in the paracetamol groupThe majority of all adverse events was considered to be either mild or not in relation to the treatment. Children with known hypersensitivity to paracetamol or NSAIDs were excluded